30571-56-3

Basic information

• Product Name: SYRUP
• Synonyms: SYRUP;1,2,3,5-TETRA-O-ACETYL-D-XYLOFURANOSE
• CAS NO: 30571-56-3
• Molecular Formula: C₁₃H₁₈O₉
• Molecular Weight: 318.28
• Mol File: 30571-56-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 410.177 °C at 760 mmHg
• Flash Point: 180.013 °C
• Appearance: /
• Density: 1.246 g/cm³
• Vapor Pressure: 6.14E-07mmHg at 25°C
• Refractive Index: 1.455
• CAS DataBase Reference: SYRUP(CAS DataBase Reference)
• NIST Chemistry Reference: SYRUP(30571-56-3)
• EPA Substance Registry System: SYRUP(30571-56-3)

Safety Data

• Hazardous Substances Data: 30571-56-3(Hazardous Substances Data)

Usage

Description

SYRUP, commercially known as an aqueous solution of cane or beet sugar (sucrose), is widely used in the manufacturing of various products such as candy, soft drinks, and soda-fountain goods. The USP grade of SYRUP is an aqueous solution of cane sugar with a concentration of 85 g/100 mL and has a viscous liquid property with a density of 1.313.

Uses

Used in Candy Manufacturing:
SYRUP is used as a sweetening agent for enhancing the taste and texture of candies. Its high sugar content provides the desired sweetness and contributes to the formation of the candy's structure.
Used in Soft Drink Industry:
In the soft drink industry, SYRUP is used as a primary ingredient to add sweetness and flavor to beverages. It is often mixed with carbonated water, flavorings, and other additives to create a wide range of soft drinks.
Used in Soda-Fountain Goods:
SYRUP is used as a key component in the preparation of various soda-fountain goods, such as flavored syrups for fountain drinks, milkshakes, and smoothies. Its viscosity and sweetness play a crucial role in achieving the desired taste and consistency of these products.
Used in Pharmaceutical Industry:
SYRUP is also used in the pharmaceutical industry as a vehicle for delivering medications, particularly in the form of cough syrups and elixirs. Its thick, viscous nature helps to coat the throat and provide relief from cough and irritation.
Used in Cosmetics and Personal Care Industry:
In the cosmetics and personal care industry, SYRUP is used as an ingredient in various products such as lotions, creams, and shampoos. Its humectant properties help to retain moisture and provide a smooth, silky texture to the products.
Used in Food Industry:
SYRUP is widely used in the food industry as a natural sweetener and flavor enhancer. It is commonly found in baked goods, desserts, and confectionery items, where it adds sweetness, moisture, and a rich taste to the final product.

Defination

Commercial name for an aqueous solution of cane or beet sugar (sucrose) sold in tank car lots to manufacturers of candy, soft drinks, soda-fountain goods, etc. USP grade is an aqueous solution of cane sugar (85 g/100 mL). A viscous liquid with d 1.313.

InChI:InChI=1/C13H18O9/c1-7(15)19-6-12(21-9(3)17)13(22-10(4)18)11(5-14)20-8(2)16/h5,11-13H,6H2,1-4H3

Upstream product

• 7226-49-5 2,3,4,5-tetra-O-acetyl-D-xylose diethyl dithioacetal 
• 58-86-6 D-xylose 
• 108-24-7 acetic anhydride 
• 59-23-4 D-Galactose 

Downstream Products

• 7208-41-5 penta-O-acetyl-6-deoxy-L-glucitol 
• 7208-41-5 penta-O-acetyl-1-deoxy-D-iditol 
• 3615-56-3 D-Sorbose 
• 86334-50-1 1-deoxy-D-gulitol 

Relevant articles and documents

Indiosides G-K: Steroidal glycosides with cytotoxic and anti-inflammatory activities from Solanum violaceum

Five new steroidal glycosides (1-5) and nine known compounds were isolated from Solanum violaceum. Indiosides G (1) and H (2) are spirostene saponins with an iso-type F ring, indioside I (3) is a spirostane saponin, and indiosides J (4) and K (5) are unusual furostanol saponins with a deformed F ring. These structures represent rare naturally occurring steroidal skeletons. The structures of the new compounds were elucidated using 1D and 2D spectroscopic techniques and acid hydrolysis. Compounds 2, 3, and 7-9 exhibited cytotoxic activity against six human cancer cell lines (HepG2, Hep3B, A549, Ca9-22, MDA-MB-231, and MCF-7) with IC50 values of 1.83-8.04 μg/mL. Steroidal saponins 3, 8, and 9 showed inhibitory effects on superoxide anion generation with IC50 values of 2.84 ± 0.18, 0.62 ± 0.03, and 1.62 ± 0.59 μg/mL, respectively. Saponins 8 and 9 also inhibited elastase release with IC50 values of 111.05 ± 7.37 and 4.04 ± 0.51 μg/mL, respectively. Structure-activity relationship correlations of these compounds with respect to cytotoxic and anti-inflammatory effects are discussed.

C-GLYCOSIDE ANALOGUES OF N-(4-HYDROXYPHENYL)RETINAMIDE-O-GLUCURONIDE

The present invention provides breast cancer chemopreventive arylamide analogues of retinoic acid, more particularly C-glycoside analogues of N-(4-hydroxyphenyl)retinamide-O-glucuronide and N-glycoside analogue of retinoyl beta-glucuronide that resist both beta-glucuronidase mediated enzymatic hydrolysis as well as acid catalyzed hydrolysis. Specifically, the drugs include 4-(retinamido)phenyl-C-glucuronide; 4-(retinamido)phenyl-C-glucoside; 4-(retinamido)benzyl-C-xyloside; 4-(retinamido)benzyl-C-glucoside; 4-(retinamido)benzyl-C-glucuronide; 4-(retinamido)phenyl-C-xyloside, 1-(B-D-lucopyranosyl) retinamide and 1-(D-glucopyranosyluronosly) retinamide. The invention also relates to a method for making such drugs.